Normal fibroblasts showed rhythmic oscillations of glycolysis and mitochondrial activity whereas these rhythms were disrupted in patient‐derived fibroblasts, which were collected from early‐onset PD patients with carriers of PARK2 mutation (Pacelli et al., 2019). This evidence concerns the gene PRKN and Parkinson disease.